Latest Breaking News On - Ikena oncology - Page 3 : comparemela.com

IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024

IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Ikena-oncology
Place-earnings

Adaptive Biotechnologies (NASDAQ:ADPT) & Ikena Oncology (NASDAQ:IKNA) Head to Head Comparison

Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) and Ikena Oncology (NASDAQ:IKNA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation. Volatility & Risk Adaptive Biotechnologies has a […]

Boston
Massachusetts
United-states
Seattle
Washington
Genentech-inc
Ikena-oncology-inc
Microsoft-corporation
Adaptive-biotechnologies-corporation
Adaptive-biotechnologies
Get-free-report

Ikena Oncology: Q4 Earnings Insights - Ikena Oncology (NASDAQ:IKNA)

Ikena-oncology

AbbVie names CEO successor—Chutes & Ladders

AbbVie names CEO successor—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Chicago
Illinois
United-states
California
Paul-hudson
Marlena-fejzo
America-ph
Robert-michael
Gabrielle-masson
Rick-gonzalez
Albert-bourla
Vivek-sharma

Oncology dealmaking fuels biotech M&A | White & Case LLP

Global spending on cancer medicines is set to reach US$375 billion by 2027, with innovation in drug discovery and development ramping up to meet rising demand. While the global biotech.

California
United-states
Massachusetts
Boston
China
France
French
Bristol-myers-squibb
Pionyr-immunotherapeutics
Ambrx-biopharma
Eli-lilly
White-case